Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
23.18B | 6.79B | 6.25B | 19.14B | 16.39B | 13.90B | Gross Profit |
29.87B | 6.79B | 6.25B | 6.56B | 6.89B | 5.18B | EBIT |
6.10B | -6.09B | -6.15B | 7.01B | 9.28B | 4.05B | EBITDA |
-178.00M | 20.52B | 18.58B | 14.76B | 8.58B | 6.49B | Net Income Common Stockholders |
3.47B | 3.71B | 3.52B | 5.18B | 4.71B | 3.02B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
83.90B | 88.04B | 83.90B | 87.79B | 103.57B | 40.17B | Total Assets |
403.40B | 445.22B | 403.40B | 389.41B | 399.18B | 245.65B | Total Debt |
269.21B | 330.19B | 269.21B | 141.79B | 140.47B | 85.47B | Net Debt |
237.36B | 303.80B | 237.36B | 96.14B | 87.72B | 67.04B | Total Liabilities |
369.41B | 409.43B | 369.41B | 355.31B | 370.37B | 223.30B | Stockholders Equity |
33.48B | 35.36B | 33.48B | 33.16B | 28.56B | 22.05B |
Cash Flow | Free Cash Flow | ||||
-18.09B | 5.27B | -6.05B | -12.20B | 9.57B | -2.40B | Operating Cash Flow |
-16.13B | 6.33B | -4.09B | -11.38B | 10.55B | -1.64B | Investing Cash Flow |
-11.99B | -2.34B | -3.88B | -1.23B | -31.13B | -11.13B | Financing Cash Flow |
17.16B | -1.94B | -2.99B | 450.00M | 72.19B | 20.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $86.43B | 28.23 | 19.26% | 0.62% | 14.67% | 23.59% | |
78 Outperform | $160.80B | 26.56 | 14.12% | 1.22% | 2.32% | 37.66% | |
77 Outperform | $29.81B | 14.23 | 18.84% | 1.34% | 11.78% | 25.68% | |
72 Outperform | $191.52B | 14.49 | 12.26% | 1.92% | 7.70% | 68.64% | |
72 Outperform | $51.43B | 22.16 | 10.63% | 3.45% | 6.28% | 5.37% | |
71 Outperform | $211.47B | 15.47 | 13.88% | 2.80% | 6.53% | 55.54% | |
64 Neutral | $12.93B | 9.70 | 7.85% | 78.03% | 12.07% | -7.83% |